Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

284.71 USD -1.91 (-0.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 783,862
Open 290.82
Bid (Size) 285.00 (1)
Ask (Size) 287.25 (4)
Prev. Close 286.62
Today's Range 284.25 - 291.54
52wk Range 223.25 - 468.35
Shares Outstanding 149,033,443
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer's Disease Under The Accelerated Approval Pathway
Lecanemab Is An Anti-Amyloid Beta (Aβ) Protofibril Antibody 
From PR Newswire
Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative
Tags Healthy Climate Healthy Lives NASDAQ:BIIB Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
+17.19%
+17.19%
1 Month
-17.34%
-17.34%
3 Month
-16.33%
-16.33%
6 Month
+3.13%
+3.13%
1 Year
+0.95%
+0.95%

More News

Read More
Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multiple Novel Therapies in Neuroscience
From GlobeNewswire News Releases
FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab-nuna)
From GlobeNewswire News Releases
FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab-nuna)
From GlobeNewswire News Releases
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Tags News BIIB Benzinga
From Benzinga
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More
Tags Trading Ideas Nike Benzinga
From Benzinga
Noteworthy Friday Option Activity: M, KMPH, BIIB
Tags Stocks
From Market News Video
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
Tags Top Stories Market News Needham
From Benzinga
Is Cassava Sciences Back in the Game?
Tags SAVA Market News BIIB
From Motley Fool
Where Biogen Stands With Analysts
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.